As Novo Ups The Ante In Canada For Semaglutide, Can Dr Reddy’s Get To Market In Time?

 
• By Anju Ghangurde
  
Dr Reddy's gears for semaglutide opportunity (Shutterstock)

More from Earnings

More from Business